Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Medtronic Gets New FDA Infuse OK - Medical Product Outsourcing

Medtronic Gets New FDA Infuse OK

Minneapolis, MN-based Medtronic said that the FDA expanded the marketing approval of the company’s Infuse bone graft for a variety of dental and facial reconstruction uses, according to the Associated Press.

Specifically, the agency approved Infuse for certain oral maxillofacial and dental regenerative bone grafting procedures. The affected area comprises the head, neck, face, jaws and the hard and soft tissues. The medical device manufacturer estimates the new approval will allow Infuse to be used in more than 350,000 bone grafting procedures per year, when previously a patient’s own bone needed to be harvested from other sites for a graft.

The FDA approval marks the third one the company has received since 2002. Infuse is already approved for certain lumbar spine fusion and tibial fracture repair procedures.

Infuse is a human bone protein that is applied to an absorbable collagen sponge carrier and is designed to stimulate bone growth.

Add us as a preferred source on Google

Get the latest Medical Product Outsourcing news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters